Company / Income Tax
Dexcom Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$252.1M
FY2025
5-year range
-$251.8M / $252.1M
FY2021-FY2025
Trend
+89.8%
vs FY2024
Sector context
#23 of 162
Health Care
What the data says
Dexcom's income tax of $252M is higher than 86% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$252M in FY2022 to $252M in FY2025.
Based on SEC 10-K filings.
$252M in FY2025. Top quartile in the Health Care sector.
Increased from $169M to $252M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 162This company $252.1M Sector average $145.4M
▼
+73.4% above sector average
Key checks
Key Insights
- In FY2025, income tax increased 89.8% year-over-year.
- Ranks #23 out of 162 companies in the Health Care sector.
- Lowest income tax in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $252.1M | +89.8% |
| FY2024 | $132.8M | -21.4% |
| FY2023 | $168.9M | +167.1% |
| FY2022 | -$251.8M | -731.1% |
| FY2021 | $39.9M | +115.8% |
| FY2020 | -$251.8M | -8222.6% |
| FY2019 | $3.1M | +416.7% |
| FY2018 | $600.0K | +500.0% |
| FY2017 | $100.0K | +0.0% |
| FY2016 | $100.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026